Versant Ventures V (Canada), L.P.

Versant Ventures V (Canada), L.P. insider trades: Turnstone Biologics (TSBX) stock buys and sales

Turnstone Biologics Last trade Jul 25, 2023 15 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2019
5
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Versant Ventures V (Canada), L.P. reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 25, 2023TSBX↑ Buy$2.4M
Jul 25, 2023TSBX↑ Buy$180K
Jul 25, 2023TSBX↑ Buy$79K
Jul 25, 2023TSBX↑ Buy$71K
Jun 3, 2022RPTX↓ Sell$9.2M
Jun 23, 2020RPTX↑ Buy$5.0M
Oct 7, 2019APRE↑ Buy$5.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Versant Ventures V (Canada), L.P.'s insider trades

Versant Ventures V (Canada), L.P. is an insider at Turnstone Biologics (TSBX). Since Oct 7, 2019, it has reported 6 open-market purchases worth $12.7M and 1 sale worth $9.2M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (12 filings), conversions (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TSBX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.